Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AstraZeneca's BYDUREON BCise Injectable Medicine Now Available in the U.S. for Patients With Type-2

biospaceJanuary 11, 2018

Tag: AstraZeneca , BYDUREON BCise

PharmaSources Customer Service